Drug Type Proteolysis-targeting chimeras (PROTAC) |
Synonyms- |
Target |
Mechanism XIAP inhibitors(Inhibitor of apoptosis protein 3 inhibitors), cIAP1/cIAP2 inhibitors(cIAP1/cIAP2 inhibitors) |
Therapeutic Areas |
Active Indication |
Inactive Indication- |
Originator Organization |
Active Organization |
Inactive Organization- |
Drug Highest PhasePreclinical |
First Approval Date- |
Regulation- |
Molecular FormulaC54H68N8O9 |
InChIKeySRDCVVVXPHPDOL-ARTZEGNBSA-N |
CAS Registry- |
Indication | Highest Phase | Country/Location | Organization | Date |
---|---|---|---|---|
Neoplasms | Preclinical | KR | 09 Nov 2022 |